Tower Research Capital (TRC)’s Elicio Therapeutics ELTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-611
| Closed | -$3.12K | – | 5337 |
|
|
2024
Q4 | $3.12K | Sell |
611
-339
| -36% | -$1.73K | ﹤0.01% | 4713 |
|
|
2024
Q3 | $4.78K | Buy |
+950
| New | +$4.78K | ﹤0.01% | 4427 |
|
|
2024
Q1 | – | Sell |
-2,045
| Closed | -$17.1K | – | 5928 |
|
|
2023
Q4 | $17.1K | Buy |
2,045
+2,007
| +5,282% | +$16.7K | ﹤0.01% | 3750 |
|
|
2023
Q3 | $321 | Sell |
38
-131
| -78% | -$1.11K | ﹤0.01% | 5606 |
|
|
2023
Q2 | $1.61K | Sell |
169
-452
| -73% | -$4.3K | ﹤0.01% | 5325 |
|
|
2023
Q1 | $4K | Buy |
621
+263
| +73% | +$1.69K | ﹤0.01% | 5058 |
|
|
2022
Q4 | $3K | Buy |
358
+113
| +46% | +$947 | ﹤0.01% | 5172 |
|
|
2022
Q3 | $2K | Buy |
245
+135
| +123% | +$1.1K | ﹤0.01% | 5550 |
|
|
2022
Q2 | $1K | Sell |
110
-354
| -76% | -$3.22K | ﹤0.01% | 5775 |
|
|
2022
Q1 | $10K | Buy |
464
+43
| +10% | +$927 | ﹤0.01% | 4298 |
|
|
2021
Q4 | $12K | Buy |
421
+308
| +273% | +$8.78K | ﹤0.01% | 4269 |
|
|
2021
Q3 | $11K | Buy |
113
+4
| +4% | +$389 | ﹤0.01% | 4216 |
|
|
2021
Q2 | $14K | Buy |
109
+36
| +49% | +$4.62K | ﹤0.01% | 4170 |
|
|
2021
Q1 | $13K | Buy |
+73
| New | +$13K | ﹤0.01% | 4200 |
|